TABLE 2

MICs of K. oxytoca isolates obtained during on-site inspection of risk areas

No.SpeciesSample typeMIC (mg/liter)a
PiperacillinPiperacillin-tazobactamCefotaximeCeftazidimeImipenemMeropenemAmikacinCiprofloxacin
1K. oxytocaWashing machineR (>16)I (16/4)R (>2)R (32)S (≤1)S (≤0.125)S (≤4)R (2)
2K. oxytocaWashing machineR (>16)R (>64/4)R (>2)R (32)S (≤1)S (≤0.125)S (8)R (2)
3K. oxytocaWashing machineR (>16)R (64/4)R (>2)R (32)S (≤1)S (≤0.125)S (8)R (2)
4K. oxytocaSiphon from wash basin in staff lobbyR (>16)R (32/4)R (>2)R (32)S (≤1)S (≤0.125)S (8)R (>2)
5K. oxytocaSiphon from wash basin in staff lobbyR (>16)S (8/4)R (>2)R (32)S (≤1)S (≤0.125)S (≤4)R (2)
6K. oxytocaSiphon from wash basin in staff lobbyR (>16)I (16/4)R (>2)R (64)S (≤1)S (≤0.125)S (≤4)R (2)
7K. oxytocaHumanR (>16)R (>64/4)R (>2)R (>128)S (≤1)S (≤0.125)I (16)R (>2)
8K. oxytocaHumanR (>16)R (>64/4)R (>2)R (>128)S (≤1)S (≤0.125)S (8)R (>2)
9K. oxytocaHumanR (>16)R (>64/4)R (>2)R (>128)S (≤1)S (≤0.125)S (8)R (>2)
10K. oxytocaHumanR (>16)R (>64/4)R (>2)R (>128)S (≤1)S (≤0.125)S (≤4)R (>2)
11K. oxytocaHumanR (>16)R (>64/4)R (>2)R (>128)S (≤1)S (≤0.125)S (8)R (>2)
12K. oxytocaHumanR (>16)R (>64/4)R (>2)R (>128)S (≤1)S (≤0.125)S (≤4)R (>2)
13K. oxytocaHumanR (>16)R (>64/4)R (>2)R (>128)S (≤1)S (≤0.125)S (≤4)R (2)
14K. oxytocaHumanR (>16)R (>64/4)R (>2)R (>128)S (≤1)S (≤0.125)S (≤4)R (>2)
15K. oxytocaHumanR (>16)R (>64/4)R (>2)R (>128)S (≤1)S (≤0.125)S (8)R (>2)
16K. oxytocaHumanR (>16)R (>64/4)R (>2)R (>128)S (≤1)S (≤0.125)S (≤4)R (>2)
  • a R, resistant; I, intermediate; S, sensitive.